North America Smart Pills Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Jun 2020
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

North America Smart Pills Market, By Type (Multiparameter Monitoring, Single Parameter Monitoring), Disease Indication (Occult GI Bleeding, Crohn’s Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes, Mental Disorders), Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring of Cancer), End User (Hospital, Diagnostic Centers, Others),  Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2027

North America Smart Pills Market

Market Analysis and Insights: North America Smart Pills Market

Smart pills market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 10.96 billion by 2027 growing at a CAGR of 16.21% in the above-mentioned forecast period. The rising preference of patient towards minimally invasive surgeries will help in driving the growth of the smart pills market.

The favourable reimbursement coverage in selected countries, technological advancements in capsule endoscopes and growing incidences of colon cancer will likely to accelerate the growth of the smart pills market in the forecast period of 2020-2027. On the other hand, rise in necessity of rapid drug development process will further boost various opportunities that will lead to the growth of the smart pills market in the above mentioned forecast period.

Growing sophistication in smart pills to increase the costs and technological incompetence of capsule endoscopes is likely to hamper the growth of the smart pills market in the above mentioned forecast period.

This smart pills market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on smart pills market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Smart Pills Market Scope and Market Size

Smart pills market is segmented on the basis of type, disease indication, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on type, the smart pills market is segmented into multiparameter monitoring and single parameter monitoring.
  • On the basis of disease indication, the smart pills market is segmented into occult GI bleeding, Crohn’s disease, small bowel tumors, celiac disease, inherited polyposis syndromes and mental disorders.
  • Based on application, the smart pills market is segmented into capsule endoscopy, drug delivery and patient monitoring of cancer.
  • Smart pills market has also been segmented based on the end user into hospital, diagnostic centers and others.

Smart Pills Market Country Level Analysis

Smart pills market is analysed and market size insights and trends are provided by country, type, disease indication, application and end user as referenced above.

The countries covered in the North America smart pills market report are the U.S., Canada and Mexico.

North America dominates the smart pills market due to strong hold of the U.S. in FDA, favourable reimbursement scenario and other approvals for smart pills technology-based products along with increasing investments by government and other agencies.

The country section of the smart pills market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Smart pills market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for smart pills market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the smart pills market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Smart Pills Market Share Analysis

Smart pills market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to smart pills market.

The major players covered in the smart pills market report are ACAMP, BDD Ltd, Boston Scientific Corporation, Cerner Corporation., FUJIFILM Holdings Corporation, GENERAL ELECTRIC COMPANY, MEDTRONIC, Olympus Corporation, PENTAX Medical, Proteus Digital Health, among other domestic players. Market share data is available for North America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: North America Smart Pills Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES NORTH AMERICA SMART PILLS MARKET

TABLE 1 DIFFERENT CURRENT PROCEDURAL TERMINOLOGY (CPT) CODES FOR CAPSULE ENDOSCOPY PROCEDURES

TABLE 2 PRICES FOR THE CAPSULE ENDOSCOPY

TABLE 3 NORTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2016-2025, (USD MILLION)

TABLE 4 NORTH AMERICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 5 NORTH AMERICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 6 NORTH AMERICA DRUG DELIVERY IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 7 NORTH AMERICA PATIENT MONITORING OF CANCER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 8 NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025, (USD MILLION)

TABLE 9 NORTH AMERICA OCCULT GI BLEEDING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 10 NORTH AMERICA CROHN’S DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 11 NORTH AMERICA SMALL BOWEL TUMORS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 12 NORTH AMERICA CELIAC DISEASE IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 13 NORTH AMERICA INHERITED POLYPOSIS SYNDROMES IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 14 NORTH AMERICA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 15 NORTH AMERICA MENTAL DISORDERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 16 NORTH AMERICA SMART PILLS MARKET, BY TYPE, 2016-2025, (USD MILLION)

TABLE 17 NORTH AMERICA MULTIPARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 18 NORTH AMERICA SINGLE PARAMETER MONITORING IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 19 NORTH AMERICA SMART PILLS MARKET, BY END USER, 2016-2025, (USD MILLION)

TABLE 20 NORTH AMERICA HOSPITAL IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 21 NORTH AMERICA DIAGNOSTIC CENTERS IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 22 NORTH AMERICA OTHERS END USER IN SMART PILLS MARKET, BY REGION, 2016-2025 (USD MILLION)

TABLE 23 NORTH AMERICA SMART PILLS MARKET, BY COUNTRY, 2016-2025 (USD MILLION)

TABLE 24 NORTH AMERICA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 25 NORTH AMERICA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 26 NORTH AMERICA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 27 NORTH AMERICA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 28 NORTH AMERICA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 29 NORTH AMERICA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 30 U.S. SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 31 U.S. CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 32 U.S. SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 33 U.S. MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 34 U.S. SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 35 U.S. SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 36 CANADA SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 37 CANADA CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 38 CANADA SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 39 CANADA MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 40 CANADA SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 41 CANADA SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

TABLE 42 MEXICO SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 43 MEXICO CAPSULE ENDOSCOPY IN SMART PILLS MARKET, BY APPLICATION, 2016-2025 (USD MILLION)

TABLE 44 MEXICO SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 45 MEXICO MENTAL DISORDERS IN SMART PILLS MARKET, BY DISEASE INDICATION, 2016-2025 (USD MILLION)

TABLE 46 MEXICO SMART PILLS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 47 MEXICO SMART PILLS MARKET, BY END USER, 2016-2025 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19